| 000 | 01581 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516201705.0 | ||
| 264 | 0 | _c20150105 | |
| 008 | 201501s 0 0 eng d | ||
| 022 | _a1365-2710 | ||
| 024 | 7 |
_a10.1111/jcpt.12143 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAn, S H | |
| 245 | 0 | 0 |
_aAssociation of gene polymorphisms with the risk of warfarin bleeding complications at therapeutic INR in patients with mechanical cardiac valves. _h[electronic resource] |
| 260 |
_bJournal of clinical pharmacy and therapeutics _cJun 2014 |
||
| 300 |
_a314-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
| 650 | 0 | 4 |
_aC-Reactive Protein _xgenetics |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP2C9 _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHeart Valve Prosthesis |
| 650 | 0 | 4 |
_aHemorrhage _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInternational Normalized Ratio |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
| 650 | 0 | 4 | _aRepublic of Korea |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aThrombomodulin _xgenetics |
| 650 | 0 | 4 |
_aVitamin K Epoxide Reductases _xgenetics |
| 650 | 0 | 4 |
_aWarfarin _xadverse effects |
| 700 | 1 | _aLee, K E | |
| 700 | 1 | _aChang, B C | |
| 700 | 1 | _aGwak, H S | |
| 773 | 0 |
_tJournal of clinical pharmacy and therapeutics _gvol. 39 _gno. 3 _gp. 314-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/jcpt.12143 _zAvailable from publisher's website |
| 999 |
_c23615816 _d23615816 |
||